Radiation Oncology/Therapy: Page 249

IBA revenues increase by 20% in Q1
By AuntMinnie.com staff writers
Radiopharmaceutical developer Ion Beam Applications (IBA) reported nearly 20% revenue growth in its first quarter.
May 11, 2011
FEC-PET/CT helps direct radiation to prostate tumors
By Wayne Forrest
F-18 fluoroethylcholine (FEC) with PET/CT is showing early promise for radiation treatment planning of recurrent and primary prostate cancer, with greater doses of radiation delivered to PET/CT-positive lymph nodes, according to a study published online May 1 in Radiation Oncology.
May 11, 2011
PET/CT helps target radiation therapy of NSCLC tumors
By Becky McCall
LONDON - PET/CT prior to radiotherapy can help oncologists target a more powerful dose of radiation to non-small cell lung cancer (NSCLC), whilst keeping dose low in other areas of the organ, according to research presented at this week's European Society for Therapeutic Radiology and Oncology meeting.
May 11, 2011
2011 05 11 14 00 56 747 Estro Clinical 394
Brainlab gets clearance for HybridArc
By AuntMinnie.com staff writers
Image-guided therapy firm Brainlab has received U.S. Food and Drug Administration 510(k) clearance for its HybridArc radiosurgery planning software.
May 10, 2011
Hitachi lands Mayo Clinic proton therapy order
By AuntMinnie.com staff writers
Hitachi will provide the Mayo Clinic with two proton beam therapy systems, which will be installed at Mayo facilities in Rochester, MN, and Phoenix.
May 9, 2011
2nd lumpectomy an option for recurrent breast cancer
By Cynthia E. Keen
Women who have recurring breast cancer after breast conservation surgery and radiation therapy seldom have the option to save their breast -- a mastectomy is the recommended treatment. However, there may be another option, according to an article published in the April issue of Brachytherapy.
May 9, 2011
IBA, Philips join forces in proton therapy
By AuntMinnie.com staff writers
Radiopharmaceutical developer Ion Beam Applications (IBA) and Royal Philips Electronics have inked a deal to create proton therapy centers.
May 8, 2011
Delayed I-131 therapy can be costly for thyroid patients
By Wayne Forrest
Delaying initial radioactive iodine-131 (I-131) therapy more than 180 days after total thyroidectomy may result in poor survival for thyroid carcinoma patients, according to a study published in the May issue of the Journal of Nuclear Medicine.
May 8, 2011
Accuray revenue climbs in Q3
By AuntMinnie.com staff writers
Radiation therapy firm Accuray posted a 5% increase in revenue in its fiscal third quarter, but costs associated with its pending acquisition of TomoTherapy pushed the firm into the red.
May 5, 2011
AuntMinnie.com Radiation Oncology Insider
By Cynthia E. Keen
May 4, 2011
Xoft buy a mixed bag for iCAD's Q1
By AuntMinnie.com staff writers
Computer-aided detection firm iCAD reported higher sales -- but also a bigger net loss -- in the first quarter of 2011, which the company attributed to the inclusion of financial results from its recent purchase of brachytherapy device developer Xoft.
May 4, 2011
ASTRO issues thoracic radiotherapy guidelines
By AuntMinnie.com staff writers
The American Society for Radiation Oncology (ASTRO) has issued evidence-based guidelines for the use of external-beam radiation therapy, endobronchial brachytherapy, and concurrent chemotherapy to provide palliative care and treat thoracic symptoms caused by advanced lung cancer.
May 3, 2011
Previous Page
Page 249 of 468
Next Page